Keywords: Arterial Spin Labelling, Machine Learning/Artificial Intelligence, Classification, disease progression
Motivation: CBF is a surrogate biomarker for early AD detection and diagnostic progression, as it reflects vascular dysregulation linked to AD pathology.
Goal(s): To predict AD diagnostic label and MCI conversion using ASL data from ADNI-3.
Approach: We trained SVM classifiers with harmonised CBF values, demographic covariates and scanner types. Performance was validated across multiple binary classifications. Data augmentation and feature selection were used to enhance model robustness.
Results: High specificity of 0.98 was achieved in distinguishing AD and CN/MCI groups, with limitations in CN vs. MCI. The classifiers also effectively identified stable vs. converting MCI cases.
Impact: CBF-based classifiers using ASL-MRI offer a promising non-invasive approach to early AD diagnosis and tracking disease progression. It could add value to the current neuroimaging and fluid-based biomarkers.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords